This company has been marked as potentially delisted and may not be actively trading. Catalent (CTLT) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Catalent (NYSE:CTLT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.31%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$1.16 M Get CTLT Insider Trade Alerts Want to know when executives and insiders are buying or selling Catalent stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CTLT Insider Buying and Selling by Quarter Catalent Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/11/2024Michelle R RyanDirectorSell2,800$59.70$167,160.00 10/18/2024Joseph Anthony FerraroSVPSell320$59.97$19,190.40 9/26/2024David McerlaneInsiderSell1,994$59.97$119,580.18 8/2/2024Ricky HopsonInsiderSell662$59.56$39,428.72 8/2/2024Scott GuntherSVPSell666$59.55$39,660.30 7/29/2024Alessandro MaselliCEOSell9,088$58.76$534,010.88 7/8/2024Matti MasanovichCFOSell2,993$56.74$169,822.82 6/4/2024Ricky HopsonInsiderSell1,401$54.26$76,018.26 (Data available from 1/1/2013 forward) CTLT Insider Trading Activity - Frequently Asked Questions Who is on Catalent's Insider Roster? The list of insiders at Catalent includes Alessandro Maselli, Aristippos Gennadios, Charles Lickfold, David Mcerlane, John J Greisch, Joseph Anthony Ferraro, Kay A Schmidt, Manja Boerman, Mario Gargiulo, Matti Masanovich, Michael A Riley, Michael J Grippo, Michelle R Ryan, Ricardo Pravda, Ricky Hopson, Scott Gunther, Steven L Fasman, Thomas P Castellano, and Thomas W Hawkeswood. Learn more on insiders at CTLT. What percentage of Catalent stock is owned by insiders? 0.31% of Catalent stock is owned by insiders. Learn more on CTLT's insider holdings. Which Catalent insiders have been buying company stock? The following insiders have purchased CTLT shares in the last 24 months: John J Greisch ($1,055,040.00), and Michelle R Ryan ($49,980.00). How much insider buying is happening at Catalent? Insiders have purchased a total of 22,000 CTLT shares in the last 24 months for a total of $1,105,020.00 bought. Which Catalent insiders have been selling company stock? The following insiders have sold CTLT shares in the last 24 months: Alessandro Maselli ($696,241.27), Aristippos Gennadios ($17,618.04), Charles Lickfold ($6,466.50), David Mcerlane ($119,580.18), Joseph Anthony Ferraro ($19,190.40), Matti Masanovich ($169,822.82), Michelle R Ryan ($167,160.00), Ricardo Pravda ($12,793.64), Ricky Hopson ($115,446.98), Scott Gunther ($73,399.03), and Steven L Fasman ($36,479.05). How much insider selling is happening at Catalent? Insiders have sold a total of 25,753 Catalent shares in the last 24 months for a total of $1,434,197.91 sold. Catalent Key ExecutivesMr. Alessandro Maselli (Age 52)President & CEO Compensation: $1.08MDr. Aristippos Gennadios Ph.D. (Age 58)Group President of Pharma & Consumer Health Segment Compensation: $799.26kMr. Ricky Hopson (Age 47)President, Division Head for BioProduct Delivery & Chief of Staff Compensation: $622.12kMr. John J. Greisch M.B.A. (Age 69)Executive Chairman of the Board Compensation: $125kMr. Matti M. Masanovich (Age 52)Senior VP & CFO Mr. Michael J. Hatzfeld Jr. (Age 50)VP & Chief Accounting Officer Mr. Charles Lickfold (Age 50)Senior VP & Chief Information Officer Mr. Paul SurdezVice President of Investor RelationsMr. Joseph A. Ferraro J.D. (Age 45)Senior VP, General Counsel, Chief Compliance Officer & Secretary Mr. Michael J. Grippo (Age 55)Senior Vice President of Strategy & Corporate Development More Insider Trading Tools from MarketBeat Related Companies Takeda Pharmaceutical Insider Selling argenx Insider Selling BioNTech Insider Selling Beigene Insider Selling Teva Pharmaceutical Industries Insider Selling Summit Therapeutics Insider Selling Intra-Cellular Therapies Insider Selling Genmab A/S Insider Selling Viatris Insider Selling Moderna Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NYSE:CTLT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
